|
NVDA
|
Technology |
Stifel |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$0.42
|
+2.5%
|
+3.1%
|
+3.2%
|
-0.1%
|
+1.3%
|
+3.5%
|
|
NVDA
|
Technology |
B. Riley SecuritiesB |
Upgrade
|
Neutral
→
Buy
|
—
|
$5.4T
|
$0.42
|
+2.5%
|
+3.1%
|
+3.2%
|
-0.1%
|
+1.3%
|
+3.5%
|
|
NVDA
|
Technology |
B. Riley FBRB |
Upgrade
|
Neutral
→
Buy
|
—
|
$5.4T
|
$0.42
|
+2.5%
|
+3.1%
|
+3.2%
|
-0.1%
|
+1.3%
|
+3.5%
|
|
NVDA
|
Technology |
FBR Capital |
Maintains
|
Market Perform
→
Market Perform
|
—
|
$5.4T
|
$0.42
|
+2.5%
|
+3.1%
|
+3.2%
|
-0.1%
|
+1.3%
|
+3.5%
|
|
AAPL
|
Technology |
BofA Securities |
Maintains
|
Neutral
→
Neutral
|
—
|
$4.5T
|
$19.14
|
-0.3%
|
+1.6%
|
-0.1%
|
+0.4%
|
-1.6%
|
-1.1%
|
|
AVGO
|
Technology |
JMP Securities |
Downgrade
|
Market Outperform
→
Market Perform
|
—
|
$2.0T
|
$5.89
|
-2.5%
|
+0.3%
|
-1.7%
|
+0.5%
|
-1.2%
|
+2.3%
|
|
WMT
|
Consumer Defensive |
Nomura |
Maintains
|
Buy
→
Buy
|
—
|
$1.1T
|
$24.99
|
-0.4%
|
+0.5%
|
+0.6%
|
-0.6%
|
-0.6%
|
-1.8%
|
|
COST
|
Consumer Defensive |
Nomura |
Maintains
|
Buy
→
Buy
|
—
|
$486.8B
|
$114.81
|
-0.6%
|
+0.9%
|
+0.3%
|
-0.6%
|
-0.4%
|
+0.1%
|
|
AMAT
|
Technology |
DA Davidson |
Maintains
|
Buy
→
Buy
|
—
|
$344.9B
|
$17.91
|
-0.7%
|
+5.4%
|
+0.5%
|
-0.6%
|
-0.5%
|
+1.3%
|
|
TJX
|
Consumer Cyclical |
Nomura |
Maintains
|
Buy
→
Buy
|
—
|
$169.5B
|
$30.07
|
-0.4%
|
+0.1%
|
-0.6%
|
+0.7%
|
-0.6%
|
+0.3%
|
|
RIO
|
Basic Materials |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$165.3B
|
$57.99
|
+0.3%
|
+0.3%
|
+1.3%
|
+1.5%
|
-0.0%
|
+0.2%
|
|
BKNG
|
Consumer Cyclical |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$128.1B
|
$49.87
|
-0.4%
|
+2.3%
|
+0.3%
|
+1.7%
|
-2.2%
|
+0.7%
|
|
AEM
|
Basic Materials |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$89.7B
|
$32.88
|
-2.1%
|
+1.8%
|
+0.7%
|
-0.1%
|
-4.0%
|
+5.8%
|
|
AEM
|
Basic Materials |
UBS |
Downgrade
|
Buy
→
Neutral
|
—
|
$89.7B
|
$32.88
|
-2.1%
|
+1.8%
|
+0.7%
|
-0.1%
|
-4.0%
|
+5.8%
|
|
MDLZ
|
Consumer Defensive |
Credit Suisse |
Maintains
|
Neutral
→
Neutral
|
—
|
$79.6B
|
$33.21
|
-1.0%
|
+2.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
+0.6%
|
|
NTES
|
Technology |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$73.9B
|
$14.31
|
+1.7%
|
+1.2%
|
+1.2%
|
+0.4%
|
-0.8%
|
-2.5%
|
|
ROST
|
Consumer Cyclical |
Nomura |
Maintains
|
Buy
→
Buy
|
—
|
$68.7B
|
$34.58
|
+1.5%
|
+0.6%
|
-0.2%
|
-1.6%
|
-0.8%
|
-0.2%
|
|
REGN
|
Healthcare |
Oppenheimer |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$68.5B
|
$320.38
|
-1.9%
|
+2.1%
|
-0.9%
|
+2.7%
|
-2.5%
|
+1.0%
|
|
NKE
|
Consumer Cyclical |
Nomura |
Maintains
|
Buy
→
Buy
|
—
|
$63.1B
|
$37.06
|
-0.4%
|
+1.0%
|
+0.2%
|
+0.2%
|
-0.5%
|
+1.0%
|
|
SRE
|
Utilities |
Citigroup |
Downgrade
|
Buy
→
Neutral
|
—
|
$59.6B
|
$46.22
|
-0.5%
|
+0.5%
|
+0.3%
|
+0.3%
|
-0.8%
|
+0.3%
|